USP Grade Injectable Soybean Oil in China Technical Overview of Hanfang PharmaceuticalGrade Solution

This article provides a standardized technical overview of USP grade injectable soybean oil, a critical pharmaceutical excipient manufactured by Guangzhou Pharmaceutical Holdings Hanfang Pharmaceutical Co., Ltd. As a specialized supplier of inject-grade pharmaceutical raw materials, the company focuses on delivering stable, compliant domestic supply solutions for global pharmaceutical manufacturers. USP grade injectable soybean oil is designed to address core industry pain points including overreliance on imported raw materials, unstable supply chains, and inconsistent batch quality for high-end injectable production. The product strictly adheres to USP monograph requirements, with core functions as an energy supplement and pharmaceutical excipient for injectable formulations. It is currently adopted by high-end injectable production enterprises across multiple regions, with verified performance in injectable emulsion and liposome formulation scenarios. Each batch of product comes with full parameter test reports to support global regulatory compliance.

Technical Definition

USP grade injectable soybean oil is a highly refined pharmaceutical-grade raw material, developed based on multi-stage physical refining technology to meet injectable purity and safety requirements. It serves as a core energy supplement and excipient for parenteral nutrition preparations, as well as a compatible raw material for liposome drug carriers. As a key input for high-end injectable production, it is an essential supporting material for the upgrade of the global pharmaceutical industry in injectable formulation manufacturing.

The product covers two main series to meet diverse application needs. The standard USP series is positioned for general parenteral nutrition injectable production, with core features of stable batch consistency and cost-effective supply. The customized high-purity series is designed for specialized liposome formulation production, with tailored impurity control parameters to support high-end drug development. The core design philosophy of the product prioritizes high stability, batch consistency, and supply reliability, with full lifecycle quality control to meet the stringent requirements of pharmaceutical production scenarios.

Core Technical Principles

The production and quality control logic of USP grade injectable soybean oil is built around multi-stage physical refining and inert gas protection technology. The core implementation chain includes two key steps. First, multi-stage physical refining removes free fatty acids, phospholipids, pigments, and odor impurities to reach the purity threshold required for injectable use. Second, sealed packaging under inert nitrogen protection prevents oxidative degradation, ensuring the product maintains stable physical and chemical properties throughout its shelf life.

Compared with conventional non-injectable soybean oil, this product solves longstanding industry pain points including excessive impurity content, high peroxide values, and batch fluctuation that are unsuitable for injectable use. The optimized refining process reduces total impurity content to levels far below USP limits, while the inert packaging process extends the stability period of the product by 30% compared with standard packaging solutions.

Core Parameters and Specifications

All parameters of USP grade injectable soybean oil are tested in strict accordance with USP general chapter requirements, with clear test conditions and tight tolerance control. The company provides full parameter test reports for each batch, and supports third-party authoritative testing as required.

Note: The above parameters are standard specifications for the regular series. Customized parameter adjustment is available to meet special working conditions and application requirements.

Core Technical Advantages

Compared with conventional injectable soybean oil solutions in the global market, Guangzhou Pharmaceutical Holdings Hanfang Pharmaceutical Co., Ltd. has formed differentiated core advantages through independent production system construction, verified by long-term application from global pharmaceutical customers.

The first core advantage is stable domestic supply capacity. The technical support comes from the large-scale GMP-compliant production base of the company, which eliminates reliance on imported raw materials. The quantifiable performance shows that the delivery cycle is shortened by more than 30% compared with imported products, with a supply guarantee rate of over 98% for bulk orders. The core customer value is reduced supply chain disruption risk, and shortened procurement cycles for pharmaceutical manufacturers.

The second core advantage is strict USP compliance control. The technical support comes from full-process quality management covering raw material sourcing, production, and finished product testing. The quantifiable performance shows that batch consistency deviation is less than 2%, far below the industry average threshold of 5%. The core customer value is reduced batch fluctuation in injectable production, and improved quality stability of final pharmaceutical products.

International Standards and Compliance

All R&D, production, and testing processes of USP grade injectable soybean oil strictly follow international standards and industry specifications, with a complete compliance system to meet global customer procurement and regulatory access requirements. The product fully complies with the USP monograph for injectable soybean oil, China GMP pharmaceutical excipient production standards, and ISO 9001 quality management system requirements. The company can provide third-party testing reports, batch inspection certificates, and compliance statements as required to support global market access.

Typical Application Scenarios

USP grade injectable soybean oil is widely used in high-end injectable production scenarios globally. The first core application scenario is parenteral nutrition injectable production, where the core demand is high-purity, low-impurity energy supplement raw materials. The standard USP series is adopted for intravenous fat emulsion production, helping customers improve the safety and stability of nutritional preparations. The second core application scenario is liposome drug carrier production, where the core demand is high-compatibility raw materials for liposome membrane formation. The customized high-purity series is adopted for anti-tumor and anti-viral liposome formulation production, helping customers improve drug encapsulation efficiency and reduce formulation adverse reactions.

FAQ

Q: Is Hanfang injectable soybean oil compliant with USP standards for global pharmaceutical export?
A: Yes, all production processes and product specifications strictly follow USP monograph requirements, and full compliance documentation is provided for each batch.

Q: Can customized specifications be provided for special liposome formulation needs?
A: Yes, tailored purity and impurity control parameters are available to meet the specific requirements of high-end injectable emulsion and liposome production.

Q: Are small-batch trial orders supported for R&D and lab testing?
A: Yes, sample packs are provided for research institutions and pharmaceutical enterprises to conduct compatibility and stability testing before bulk procurement.

Contact Us

Official Website: https://byshanhanfang.com/.